Polynucleotides encoding anti-CD40 antibodies
US10561728B2 · kind B2 · utility
2Cited by
41References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 29, 2018 |
| Grant date | Feb 18, 2020 |
| Priority date | — |
| Expiry date | May 29, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies specific for a particular epitope on CD40 and antibodies that bind CD40 and have particular functional characteristics. The present invention also relates to fragments of these antibodies, uses of the antibodies for reduction or treatment of transplant rejection and graft-versus-host disease, and methods for making the antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.